NCT00523796已完成不适用
InPractice Survey on the Treatment of Hypercholesterolemia
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- AstraZeneca
- 入组人数
- 2,500
- 试验地点
- 1
研究概览
简要总结
This is a multi-centre survey of patients who are currently on lipid-lowering pharmacological treatment. Data collection for each patient will take place at one visit.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Subject must be 18 years of age or older of either sex.
- •Subject is on lipid-lowering drug treatment for at least 3 months, with no dose change for a minimum of 6 weeks.
排除标准
- •Subjects who are unwilling or unable to provide informed consent.
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Survey of Lipid Goal Attainment and Mortality in Patients With High Cardiovascular Risk in ThailandDyslipidemiaNCT00684151AstraZeneca1,240
已完成
不适用
CEntralized Pan-Russian Survey of tHE Undertreatment of hypercholeSterolemia II (CEPHEUS II)DyslipidaemiaNCT02230241AstraZeneca2,700
已完成
不适用
Centralized Pan-South African Survey on the Undertreatment of HypercholesterolaemiaUndertreatment of HypercholesterolaemiaNCT01027624AstraZeneca3,000
已完成
不适用
An Observational Study Evaluating Cholesterol Levels in Patients on Cholesterol Lowering Drugs in Jordan and LebanonHigh Blood CholesterolNCT01614561AstraZeneca1,000
招募中
不适用
Hyperlipidemia Therapy TERCET Zabrze RegistryHyperlipidemiasSecondary PreventionNCT03065543Silesian Centre for Heart Diseases25,000